John Rogers
Slat Lake Business Journal
The experiment seems to be working.
A new report in Catalyst, a publication that explores health care delivery and is published by The New England Journal of Medicine, finds that Lehi-based CivicaScript is succeeding in its strategy to lower high-priced generic medicine costs through “disruptive collaboration.”
The study reports that consumers saved an average of 64 percent when they switched to CivicaScript’s medicine after taking other versions of the same generic drug. Payers — the insurance companies that generally bear a larger share of Please log in to see the rest of this story.
